News Index March
Ranbaxy expands its European reach
Ranbaxy Laboratories, India's biggest drug maker, said Wednesday
that it would buy Terapia of Romania for $324 million to increase
sales of generic medicines in Europe...
Read Full News...
Sanofi invests in generics
market
BUDAPEST Sanofi-Aventis bought a 24.9 percent stake in the Czech
drug maker Zentiva for €430 million, the French company said
Monday, as it expands in Russia and Eastern Europe and positions
itself for growth in the market for generic drugs...
Read Full News...
Consumers: Nomisma Report
on Generic Drugs
Sales for generic drug equivalents - especially type C, non-prescription
drugs - rose steeply last year, accounting for 25.5 pc of total
drugs sales...
Read Full News...
Russia changes DLO programme
rules - How will it affect Richter and Egis?
Russia's Health Minister Mikhail Zurabov has signed a decree changing
the rules for the DLO Programme, under which the distribution of
DLO drugs is to occur by name of active ingredients or INN (International
Nonproprietary Name) rather than brand name, Citigroup analyst,
Robert Bonte-Friedheim said in an analysis...
Read Full News...
Watson Pharmaceuticals to
Acquire Andrx for $1.9 Bln (Update4)
Watson Pharmaceuticals Inc. said it will acquire Andrx Corp. for
$1.9 billion to become the third- largest maker of generic drugs.
Read Full News...
Glaxo Loses Court Bid to
Stop Generic Flonase
GlaxoSmithKline Plc has lost its legal attempt to prevent the launch
of generic versions of its allergy nasal spray, Flonase, in Europe's
biggest drug maker said on Tuesday.
Read Full News...
|
